EMD-24876
SARS-CoV-2-6P-Mut2 S protein
EMD-24876
Single-particle3.2 Å
Deposition: 14/09/2021Map released: 11/05/2022
Last modified: 21/05/2025
Sample Organism:
Severe acute respiratory syndrome coronavirus 2
Sample: SARS-2-CoV-6P-Mut2 S protein
Fitted models: 7s6i
Deposition Authors: Ozorowski G
,
Torres JL
Sample: SARS-2-CoV-6P-Mut2 S protein
Fitted models: 7s6i
Deposition Authors: Ozorowski G
,
Torres JL
Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody.
Torres JL ,
Ozorowski G ,
Andreano E ,
Liu H,
Copps J ,
Piccini G ,
Donnici L ,
Conti M ,
Planchais C ,
Planas D ,
Manganaro N ,
Pantano E,
Paciello I,
Pileri P ,
Bruel T ,
Montomoli E ,
Mouquet H ,
Schwartz O,
Sala C,
De Francesco R ,
Wilson IA ,
Rappuoli R ,
Ward AB
(2022) PNAS , 119 , e2120976119 - e2120976119
,
Ozorowski G ,
Andreano E ,
Liu H,
Copps J ,
Piccini G ,
Donnici L ,
Conti M ,
Planchais C ,
Planas D ,
Manganaro N ,
Pantano E,
Paciello I,
Pileri P ,
Bruel T ,
Montomoli E ,
Mouquet H ,
Schwartz O,
Sala C,
De Francesco R ,
Wilson IA ,
Rappuoli R ,
Ward AB
(2022) PNAS , 119 , e2120976119 - e2120976119
Grant Support:
- Bill & Melinda Gates Foundation: OPP1170236 (United States)
- Bill & Melinda Gates Foundation: INV-004923 (United States)